[1]张晓辉,张弛,刘浩钦.2型糖尿病患者合并甲状腺功能减退症的危险因素分析[J].新乡医学院学报,2023,40(3):234-237.[doi:10.7683/xxyxyxb.2023.03.007]
　ZHANG Xiaohui,ZHANG Chi,LIU Haoqin.Analysis of risk factors of hypothyroidism in patients with type 2 diabetes mellitus[J].Journal of Xinxiang Medical University,2023,40(3):234-237.[doi:10.7683/xxyxyxb.2023.03.007]
点击复制

2型糖尿病患者合并甲状腺功能减退症的危险因素分析
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年3期
页码:
234-237
栏目:
临床研究
出版日期:
2023-03-05

文章信息/Info

Title:
Analysis of risk factors of hypothyroidism in patients with type 2 diabetes mellitus
作者:
张晓辉; 张弛; 刘浩钦
(湖南师范大学附属第一医院/湖南省人民医院内分泌科一病区，湖南　长沙　410000)
Author(s):
ZHANG Xiaohui; ZHANG Chi; LIU Haoqin
(The First Ward of Endocrinology,the First Affiliated Hospital of Hunan Normal University/Hunan Provincial People′s Hospital,Changsha 410000,Hunan Province,China)
关键词:
2型糖尿病; 甲状腺功能减退症; 胰岛素抵抗; 二甲双胍
Keywords:
type 2 diabetes mellitus; hypothyroidism; insulin resistance; metformin
分类号:
R581
DOI:
10.7683/xxyxyxb.2023.03.007
文献标志码:
A
摘要:
目的探讨2型糖尿病（T2DM）患者合并甲状腺功能减退症的危险因素。
方法选择2017年1月至2018年12月湖南省人民医院收治的596例T2DM患者为研究对象。根据是否合并甲状腺功能减退症将患者分为合并甲减组和未合并甲减组，其中合并甲减组62例（10.4%），未合并甲减组534例（89.6%）。通过查阅病历收集2组患者的临床资料，包括性别、年龄、体质量指数（BMI）、糖尿病病程、既往降糖方案以及空腹血糖（FPG)、空腹C肽（FCP）、餐后C肽(PCP)、糖化血红蛋白（HbAlc）、总胆固醇（TC）、三酰甘油（TG）、低密度脂蛋白胆固醇（LDL-C）、高密度脂蛋白胆固醇（HDL-C）水平，采用改良HOMA公式评估稳态模型胰岛素抵抗指数［HOMA-IR(CP)］。采用二元logistic回归分析T2DM患者合并甲状腺功能减退症的危险因素。
结果T2DM患者的性别、年龄、糖尿病病程、既往降糖方案、FPG、FCP、PCP、HbAlc、TC、TG、HOMA-IR(CP)与合并甲状腺功能减退症有关（P<0.05）；T2DM患者的BMI、LDL-C、HDL-C与合并甲状腺功能减退症无关（P>0.05）。Logistic回归分析显示，女性、年龄>70岁、FPG、HbAlc、TG、HOMA-IR(CP)是T2DM患者合并甲状腺功能减退症的危险因素（P<0.05），服用二甲双胍是T2DM患者合并甲状腺功能减退症的保护因素（P<0.05）。
结论女性、年龄>70岁、FPG、HbAlc、TG、HOMA-IR(CP)是T2DM患者合并甲状腺功能减退症的危险因素，服用二甲双胍是T2DM患者合并甲状腺功能减退症的保护因素。
Abstract:
ObjectiveTo investigate the risk factors of hypothyroidism in patients with type 2 diabetes mellitus(T2DM).MethodsA total of 596 patients with T2DM admitted to Hunan People′s Hospital from January 2017 to December 2018 were selected as research subjects.The patients were divided into the combined hypothyroidism group （n=62）and non-combined hypothyroidism group （n=534）according to whether they had combined with hypothyroidism.Relevant clinical data of patients in the two groups were collected by consulting medical records,including gender,age,body mass index (BMI),course of diabetes,previous hypoglycemic program and fasting blood glucose(FPG),fasting C-peptide (FCP),postprandial C-peptide (PCP),hemoglobin Alc (HbAlc),total cholesterol (TC),triacylglycerol (TG),low-density lipoprotein cholesterol (LDL-C),high-density lipoprotein cholesterol (HDL-C) levels.The Homeostasis model assessment for insulin resistance（C-peptide）［HOMA-IR (CP)］ of patients in the two groups was evaluated by the modified HOMA formula.The risk factors of hypothyroidism in T2DM patients were analyzedby binary logistic regression.Results　The sex,age,course of diabetes,previous hypoglycemic program,FPG,FCP,PCP,HbAlc,TC,TG,HOMA-IR (CP) were associated with hypothyroidism in T2DM patients (P<0.05).BMI,LDL-C and HDL-C were not associated with hypothyroidism in T2DM patients (P>0.05).Logistic regression analysis showed that women,age>70 years old,FPG,HbAlc,TG,HOMA-IR (CP) were the risk factors of hypothyroidism in T2DM patients (P<0.05),and taking metformin was the protective factor of hypothyroidism in T2DM patients (P<0.05).ConclusionFemale,age>70 years old,FPG,HbAlc,TG,HOMA-IR(CP) are risk factors of hypothyroidism in T2DM patients,and taking metformin is a protective factor of hypothyroidism in T2DM patients.

参考文献/References:

［1］　中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)［J］.中华糖尿病杂志,2021,13(4):315-409.
DIABETES SOCIETY OF CHINESE MEDICAL ASSOCIATION.Guidelines for the prevention and treatment of type 2 diabetes in China (2020 edition)［J］.Chin J Diabetes Mellitus,2021,13(4):315-409.
［2］　MCDERMOTT M T.Hypothyroidism［J］.Ann Intern Med,2020,173(1):ITC1-ITC16.
［3］　MEHALINGAM V,SANOO J,BOBBY Z,et al.Thyroid dysfunction in patients with type 2 diabetes mellitus and its association with diabetic complications［J］.J Family Med Prim Care,2020,9(8):4277-4281.
［4］　TALWALKAR P,DESHMUKH V,BHOLE M.Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India:a cross-sectional observational study［J］.Diabetes Metab Syndr Obes,2019,12:369-376.
［5］　YADAV A,YADAV G A M,NARSINGRAO K K,et al.Prevalence of thyroid disorders among patients with diabetes in rural South India［J］.Diabetes Metab Syndr,2021,15(3):885-889.
［6］　李霞,周智广,亓海英,等.用空腹C肽代替胰岛素改良Homa公式评价胰岛素抵抗和胰岛β细胞功能［J］.中南大学学报（医学版）,2004,29(4):419-423.
LI X,ZHOU Z G,QI H Y,et al.Evaluation of insulin resistance and islet beta cell function using fasting C-peptide instead of insulin modified homa formula［J］.J Central South Univ(Med Sci),2004,29(4):419-423.
［7］　EOM Y S,WILSON J R,BERNET V J.Links between thyroid disorders and glucose homeostasis［J］.Diabetes Metab J,2022,46(2):239-256.
［8］　KHASSAWNEH A H,AL-MISTAREHI A,ZEIN A A M,et al.Prevalence and predictors of thyroid dysfunction among type 2 diabetic patients:a case-control study［J］.Int J Gen Med,2020,13:803-816.
［9］　DAVIS M G,PHILLIPPI J C.Hypothyroidism:diagnosis and evidence-based treatment［J］.J Midwifery Womens Health,2022,67(3):394-397.
［10］　OGBONNA S U,EZEANI I U.Risk factors of thyroid dysfunction in patients with type 2 diabetes mellitus［J］.Front Endocrinol (Lausanne),2019,10:440.
［11］　HE S L,HE Y,JIN F H,et al.Correlation analysis of IGF-1,ZAG,nesfatin-1,HbA1c levels,and type 2 diabetes mellitus complicated with hypothyroidism［J］.Medicine (Baltimore),2021,100(15):e25432.
［12］　LI Y L,YI M,DENG X Y,et al.Evaluation of the thyroid characteristics and correlated factors in hospitalized patients with newly diagnosed type 2 diabetes［J］.Diabetes Metab Syndr Obes,2022,15:873-884.
［13］　OGBONNA S U,EZEANI I U,OKAFOR C I,et al.Association between glycemic status and thyroid dysfunction in patients with type 2 diabetes mellitus［J］.Diabetes Metab Syndr Obes,2019,12:1113-1122.
［14］　MOHAMMED H S M,ABDELMAGEED R M.The relationship between type 2 diabetes mellitus and related thyroid diseases［J］.Cureus,2021,13(12):e20697.
［15］　CHOI Y M,KIM M K,KWAK M K,et al.Association between thyroid hormones and insulin resistance indices based on the Korean national health and nutrition examination survey［J］.Sci Rep,2021,11(1):21738.
［16］　BRENTA G,CABALLERO A S,NUNES M T.Case finding for hypothyroidism should include type 2 diabetes and metabolic syndrome patients:a Latin American Thyroid Society (LATS) position statement［J］.Endocr Pract,2019,25(1):101-105.
［17］　KERTESZ M,KUN S,SELLEY E,et al.A breakthrough-like effect of metformin reduces peripheral resistance to triiodothyronine in euthyroid,non-insulin-resistant,type 2 diabetic patients［J］.Endocr Connect,2021,10(7):782-788.
［18］　EOM Y S,WILSON J R,BERNET V J.Links between thyroid disorders and glucose homeostasis［J］.Diabetes Metab J,2022,46(2):239-256.
［19］　HAROON S M,KHAN K,MAQSOOD M,et al.Exploring the effect of metformin to lower thyroid-stimulating hormone in euthyroid and hypothyroid type-2 diabetic patients［J］.Cureus,2021,13(2):e13283.
［20］　WANG J J,GAO J H,FAN Q,et al.The effect of metformin on thyroid-associated serum hormone levels and physiological indexes:a meta-analysis［J］.Curr Pharm Des,2019,25(30):3257-3265.
［21］　VIGERSKY R A,FILMORENASSAR A,GLASS A R.Thyrotropin suppression by metformin［J］.J Clin Endocrinol Metab,2006,91(1):225-227.
［22］　KRYSIAK R,KOWALCZE K,OKOPIEN B.The impact of combination therapy with metformin and exogenous vitamin D on hypothalamic-pituitary-thyroid axis activity in women with autoimmune thyroiditis and high-normal thyrotropin levels［J］.J Clin Pharm Ther,2020,45(6):1382-1389.
［23］　HAROON S M,KHAN K,MAQSOOD M,et al.Exploring the effect of metformin to lower thyroid-stimulating hormone in euthyroid and hypothyroid type-2 diabetic patients［J］.Cureus,2021,13(2):e13283.
［24］　HUANG B,YANG S J,YE S D.Association between thyroid function and nonalcoholic fattyliver disease in euthyroid type 2 dia-betes patients［J］.J Diabetes Res,2020,2020:6538208.

相似文献/References:

[1]翁孝刚.2型糖尿病与胰岛B一细胞功能[J].新乡医学院学报,2002,19(03):231.
[2]张英,赵梦杨.甲状腺功能减退症28例误诊分析[J].新乡医学院学报,2002,19(05):400.
[3]汪裕荣.血脂康联合小剂量阿司匹林治疗2型糖尿病并高脂血症的长期疗效观察[J].新乡医学院学报,2002,19(05):391.
[4]型糖尿病合并高血压的胰岛素敏感性探讨.2型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[5]何伟玺.冠心病与2型糖尿病患者心率变异性对比分析[J].新乡医学院学报,2003,20(04):282.
[6]李万森,毛向莹,邱培勇.2型糖尿病合并脑梗死50例临床分析[J].新乡医学院学报,2003,20(05):353.
[7]殷国田,崔瑞花.益津降糖胶囊治疗2型糖尿病42例[J].新乡医学院学报,2003,20(05):372.
[8]新乡市第二人民医院内分泌科 河南新乡.依那普利对2型糖尿病合并高血压患者血压及胰岛素敏感性指数的影响[J].新乡医学院学报,2005,22(03):267.
[9]蒋铁桥,张群,杨刚毅,等.短期胰岛素泵强化治疗对初诊2型糖尿病患者β细胞功能的影响[J].新乡医学院学报,2010,27(04):000.
[10]王润之,黄艳群.LPIN1基因的研究进展[J].新乡医学院学报,2010,27(04):413.

更新日期/Last Update: 2023-03-05